Topics

Latest "transADVANcis Marketing Research Consultoria" News Stories - Page: 20

03:46 EST 20th February 2020 | BioPortfolio

Here are the most relevant search results for "transADVANcis Marketing Research Consultoria" found in our extensive news archives from over 250 global news sources.

More Information about transADVANcis Marketing Research Consultoria on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about transADVANcis Marketing Research Consultoria for you to read. Along with our medical data and news we also list transADVANcis Marketing Research Consultoria Clinical Trials, which are updated daily. BioPortfolio also has a large database of transADVANcis Marketing Research Consultoria Companies for you to search.

Showing "transADVANcis Marketing Research Consultoria" News Articles 476–500 of 28,000+

Probably Relevant

Amarin raises sales guidance for heart drug Vascepa, hires more sales reps for larger marketing push. https://buff.ly/2J5RihG 

Amarin raises sales guidance for heart drug Vascepa, hires more sales reps for larger marketing push. https://buff.ly/2J5RihG 


After a 3 1/2 year legal battle, secret records about Purdue Pharma’s marketing of its potent opioid painkiller OxyContin will finally be made public. https://buff.ly/2zmh0Zr 

After a 3 1/2 year legal battle, secret records about Purdue Pharma’s marketing of its potent opioid painkiller OxyContin will finally be made public. https://buff.ly/2zmh0Zr 

How Juul Hooked a Generation on Nicotine

The company planted the seeds of a public health crisis by marketing to millennials, who had low smoking rates, and it ignored evidence that teenagers were using its products.


Enzalutamide for prostate cancer gains Priority Review status from FDA

An announcement was made by Astellas Pharma and partner Pfizer that its supplemental marketing application for Xtandi, or enz -More- 

athenahealth’s “State of the Smart” Marketing Campaign Wins Gold and Silver Hatch Bowl Awards

WATERTOWN, Mass., Nov. 25, 2019 (GLOBE NEWSWIRE) Read more...

Marketing To 100-Year-Olds: How Longevity Will Transform Finance, Healthcare And Education

Stanford University is addressing a pressing and fascinating question: What happens to society when everyone starts living to 100?

Original-Research: Paion AG (von First Berlin Equity Research GmbH): Buy

Original-Research: Paion AG - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Paion AG Unternehmen: Paion AG ISIN: DE000A0B65S3 Anlass der Studie: Update ...

Original-Research: Valneva SA (von First Berlin Equity Research GmbH): Kaufen

Original-Research: Valneva SA - von First Berlin Equity Research GmbH Einstufung von First Berlin Equity Research GmbH zu Valneva SA Unternehmen: Valneva SA ISIN: FR0004056851 Anlass der Studie: H...

Academic Medical Center System Infrastructure Trends and Related Challenges for Conducting Clinical Trials

Clinical Research News Contributed Commentary | Though academic medical centers (AMCs) may differ widely, they generally share the same tripartite mission: research, medical education, and patient care. Yet, increasingly, complex clinical research systems and processes present common challenges to all of these prestigious institutions, regardless of their differences, that can weigh heavily on res...

What psychological research says about the positive side of human nature

The article in BPS Research Digest, a blog that summarizes the latest research on the brain and behavior, is a follow-up to one published last year on the 10 psychological findings that reveal the worst of human nature.  

The digital shift in pharma marketing

Indegene’s surveys in 2016 and 2019 show a spike in digital spend

In Its Path Towards Marketing, Pluristem Provides Highly Favorable Market Access Data Regarding the Critical Limb Ischemia Market in U.S.

HAIFA, Israel, Feb. 03, 2020 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing a platform of novel biological products, today announced results from a market access comprehensive research study conducted by Marwood Group, a healthcare advisory firm, for the critical limb

FTC Possibly Investigating E-Cigarette Sales And Marketing Tactics

The agency wants data from six e-cigarette makers, including Juul.

FDA OKs PerkinElmer's DMD test for newborns

PerkinElmer has obtained marketing authorization from the FDA for its GSP Neonatal Creatine Kinase-MM kit for newborn screeni -More- 

Can marketing change the world?

Chris Ross explores the ability of creative communications to change minds and habits

Improving the Quality of Dietary Research

This Viewpoint discusses methodological challenges to conducting reliable dietary research relative to processes and standards in place for drug discovery and development, and proposes modifications to the conduct of dietary research to improve its transparency, quality, and reliability.

Cancer Research Technology: How close are we to another breakthrough?

As the commercialisation arm of Cancer Research UK, Cancer Research Technology (CRT) bridges the gap between academia and industry. Keith Blundy, CEO of CRT, gives his unique perspective on recent developments in immuno-oncology and talks about the most promising areas for early-stage discovery.

UK Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities [Published by Venture Planning Group VPG] Prices from US

This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the UK molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.The report explores future marketing and technological trends in UK; provides ...

US Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities [Published by Venture Planning Group VPG] Prices from US

This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.The report explores future marketing and technological trends in US; provides ...

Time to end the federal ban on gun violence research funding

In recent weeks, the firearms controversy has again lit up the media in the United States, with clarification that anyone engaged in the business of selling firearms must get a license and conduct background checks. But, argues Fred Rivara from the Seattle Children’s Research Institute and Harborview Injury Prevention and Research Center, we may...

Cold infections may be less frequent in people with the flu

(UK Research and Innovation) People were less likely to catch either influenza or a common cold-causing rhinovirus if they were already infected with the other virus, a new study by scientists from the Medical Research Council-University of Glasgow Centre for Virus Research has found.

Research on antibiotic use desperately needed as resistance crisis looms

Overuse of antibiotics in healthcare contributes to the development of antibiotic-resistant bacteria, resulting in 2 million infections and 100,000 deaths in the US each year, but research is lacking to inform antibiotic stewardship programs aimed at reining in unnecessary use of these powerful drugs, according to new research.

Acacia Pharma (ACPH) - BARHEMSYS NDA refiling Q319, launch in Q120

Edison Investment Research - Pharmaceuticals & healthcare - Acacia Pharma: Following guidance from the US FDA, Acacia Pharma has now outlined the regulatory pathway for its lead asset, BARHEMSYS, and plans to resubmit the new drug application (NDA) in Q319. This could enable a launch in H120 if approved by the FDA. Ongoing deficiencies with Acacia’s chosen contract manufacturing organisation...

5 top myths about philanthropy

Philanthropy and partnerships We know that the global appetite for philanthropic giving is growing. But for someone thinking about giving a gift to charity, there are often a lot of questions. With the help of some of

Research England will stop favouring physical over mental health in its funding calculations

Research England has announced it will change the weighting of its funding calculations to put mental health research on a par with research into physical health.1The body previously calculated...


Quick Search

News Quicklinks